<DOC>
	<DOCNO>NCT01805427</DOCNO>
	<brief_summary>The concentration third agent antiretroviral therapy [ Non Nucleoside Reverse Transcriptase Inhibitor ( NNRTI ) , boost Protease inhibitor ( PI ) ] different accord body weight body composition therapeutic monitoring may necessary overweight HIV patient . The investigator aim measure individual trough concentration interest [ steady state NNRTI boost PI ] overweight normal weight HIV+ patient .</brief_summary>
	<brief_title>Antiretroviral Therapy Extreme Weight</brief_title>
	<detailed_description>Our primary endpoint individual trough concentration interest steady state NNRTI boost PI ; Principal outcome measure : comparison concentration patient &lt; 25kg/m2 patient &lt; 25kg/m2 Secondary endpoint : - Occurrence virologic failure - Occurrence clinical/biological adverse event - Percentage patient concentration within therapeutic range - Body composition Secondary outcome measure : comparison occurrence virologic failure , occurrence adverse event , patient concentration within therapeutic range group . Correlation body composition concentration . Methodology , study design : open-labelled monocentric study . Sample size : It descriptive experimental study involve 120 overweight subject , 120 normal weight subject Inclusion criterion : - Patients HIV+ - Patients age 18 year old . - Patient give well-informed free consent . Study design : Plasma concentration perform usual clinical follow-up . Study duration : 12 month Duration patient : 1 day Investigating center participate unit : one center enrol patient lab perform drug dosage .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Patients HIV+ receive one follow third agent HAART : efavirenz , atazanavir , darunavir Patients age &gt; 18 year old . Patient give wellinformed free consent . Patient give wellinformed free consent . Patients live France study . Treatment rifampin/rifabutin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>trough concentration</keyword>
	<keyword>weight</keyword>
	<keyword>HIV</keyword>
	<keyword>virological failure</keyword>
</DOC>